Работы, цитирующие эту работу

Работ: 3

Работа: siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model

1. Non-Coding RNAs as key regulators of interferon signaling in cancer immunotherapy: mechanistic insights and clinical prospects

   Usamah Sayed, Waleed K. Abdulsahib, S. Renuka Jyothi +6

   СтатьяCircular RNAs in diseasesClinical and Experimental Medicine2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.000780

2. Non-coding RNAs at the intersection of interferon signaling and cancer: mechanistic insights and clinical prospects

   Usamah Sayed, Waleed K. Abdulsahib, S. Renuka Jyothi +6

   СтатьяCancer-related molecular mechanisms researchCancer Treatment and Research Communications2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.005222

3. Convergence of multiplexed immunosensors, nanotechnology, and AI for early pancreatic cancer diagnosis

   Qamar Abuhassan, Ahmed Faisal Mutee, Abdulkareem Shareef +10

   СтатьяPancreatic and Hepatic Oncology ResearchClinica Chimica Acta2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.011933